Original language | English |
---|---|
Pages (from-to) | S85-S86 |
Journal | European Journal of Cancer |
Volume | 174 |
DOIs | |
State | Published - Oct 2022 |
A phase II study to evaluate the efficacy of regorafenib in C-KIT mutated metastatic malignant melanoma patients who have progressed on first-line treatment: A Multicenter Trial of Korean Cancer Study Group (UN-14–13)
K. H. Kim, H. J. Lee, S. J. Lee, M. Kim, M. S. Ahn, M. Y. Choi, N. R. Lee, M. Jung, S. J. Shin
Research output: Contribution to journal › Article › peer-review